Comparative Pharmacology
Head-to-head clinical analysis: CHLOROTRIANISENE versus DESOGESTREL AND ETHINYL ESTRADIOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLOROTRIANISENE versus DESOGESTREL AND ETHINYL ESTRADIOL.
CHLOROTRIANISENE vs DESOGESTREL AND ETHINYL ESTRADIOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Synthetic nonsteroidal estrogen; binds to estrogen receptors (ERα and ERβ), activating estrogen-responsive gene transcription, leading to estrogenic effects on reproductive tissues, bone, and other targets.
Desogestrel is a progestin that suppresses gonadotropin release, inhibiting ovulation. Ethinyl estradiol is an estrogen that provides negative feedback on the hypothalamic-pituitary axis, further suppressing ovulation and altering cervical mucus and endometrial lining to reduce sperm penetration and implantation.
12-25 mg orally once daily for palliation of advanced breast cancer in postmenopausal women; may increase to 25 mg twice daily if no response after 1 month. For prostate cancer, 12-25 mg orally once daily.
One tablet (0.15 mg desogestrel/0.03 mg ethinyl estradiol) orally once daily for 21 days, followed by 7 placebo tablets, then repeat cycle.
None Documented
None Documented
Terminal elimination half-life is approximately 10-12 hours, but due to enterohepatic recirculation and accumulation in adipose tissue, effective half-life during chronic dosing may extend to several days.
Desogestrel: terminal half-life 23-27 hours (active metabolite etonogestrel); clinically allows once-daily dosing. Ethinyl estradiol: terminal half-life 12-15 hours (range 10-20 hours) with biphasic elimination; supports daily administration.
Primarily renal (metabolites, ~60-70%), with biliary/fecal elimination as minor routes (~20-30%). Unchanged drug is minimal in urine; extensive hepatic metabolism occurs.
Desogestrel: primarily renal (approximately 60% as metabolites), 30% fecal. Ethinyl estradiol: primarily renal (approximately 40% as glucuronide conjugates), 60% fecal.
Category C
Category D/X
Estrogen
Estrogen